FDA Inspection 1266962 — Peter Charles Klatsky, M.D., Inc
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc on Mar 19, 2025 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 19, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Redwood City, CA (United States)